DISRUPTION OF THE RAF-1-HSP90 MOLECULAR-COMPLEX RESULTS IN DESTABILIZATION OF RAF-1 AND LOSS OF RAF-1-RAS ASSOCIATION

被引:414
作者
SCHULTE, TW
BLAGOSKLONNY, MV
INGUI, C
NECKERS, L
机构
[1] NCI,CLIN PHARMACOL BRANCH,BETHESDA,MD 20892
[2] NCI,PEDIAT BRANCH,BETHESDA,MD 20892
关键词
D O I
10.1074/jbc.270.41.24585
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytosolic Raf-1 exists in a high molecular weight complex with the heat shock protein Hsp90, the purpose of which is unknown. The benzoquinone ansamycin, geld-anamycin, specifically binds to Hsp90 and disrupts certain multimolecular complexes containing this protein, Using this drug, we are able to demonstrate rapid dissociation of both Raf-1-Hsp90 and Raf-1-Ras multimolecular complexes, concomitant with a markedly decreased half-life of the Raf-1 protein. Continued disruption of the Raf-1-Hsp90 complex results in apparent loss of Raf-1 protein from the cell, although Raf-1 synthesis is actually increased. Prevention of Raf-1-Hsp90 complex formation interferes with trafficking of newly synthesized Raf-1 from cytosol to plasma membrane. These data indicate that association with Hsp90 is essential for both Raf-1 protein stability and its proper localization in the cell.
引用
收藏
页码:24585 / 24588
页数:4
相关论文
共 24 条
  • [11] MIYATA Y, 1992, J BIOL CHEM, V267, P7042
  • [12] ACCELERATED DEGRADATION OF 160 KDA EPIDERMAL GROWTH-FACTOR (EGF) RECEPTOR PRECURSOR BY THE TYROSINE KINASE INHIBITOR HERBIMYCIN-A IN THE ENDOPLASMIC-RETICULUM OF A431 HUMAN EPIDERMOID CARCINOMA-CELLS
    MURAKAMI, Y
    MIZUNO, S
    UEHARA, Y
    [J]. BIOCHEMICAL JOURNAL, 1994, 301 : 63 - 68
  • [13] PERDEW GH, 1988, J BIOL CHEM, V263, P13802
  • [14] PRATT WB, 1993, J BIOL CHEM, V268, P21455
  • [15] SANCHEZ ER, 1985, J BIOL CHEM, V260, P2398
  • [16] STANCATO LF, 1993, J BIOL CHEM, V268, P21711
  • [17] ACTIVATION OF RAF AS A RESULT OF RECRUITMENT TO THE PLASMA-MEMBRANE
    STOKOE, D
    MACDONALD, SG
    CADWALLADER, K
    SYMONS, M
    HANCOCK, JF
    [J]. SCIENCE, 1994, 264 (5164) : 1463 - 1467
  • [18] TRAVERSE S, 1993, ONCOGENE, V8, P3175
  • [19] UEHARA Y, 1989, CANCER RES, V49, P780
  • [20] WARTMANN M, 1994, J BIOL CHEM, V269, P6695